RE-1-silencing transcription factor shows tumor-suppressor functions and negatively regulates the oncogenic TAC1 in breast cancer cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 11, 2009, Pages 4408-4413

  Reddy, Bobby Y ^a   Greco, Steven J ^a   Patel, Prem S ^b   Trzaska, Katarzyna A ^a   Rameshwar, Pranela ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b BROOKDALE UNIVERSITY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

REST; Substance P; Tachykinin

Indexed keywords

PREPROTACHYKININ; PREPROTACHYKININ A PROTEIN; REPRESSOR ELEMENT 1 SILENCING TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL; CANCER INHIBITION; CELL LINE; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE INDUCTION; HUMAN; HUMAN CELL; METASTASIS; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

BINDING SITES; BREAST NEOPLASMS; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PROMOTER REGIONS, GENETIC; REPRESSOR PROTEINS; SEVERITY OF ILLNESS INDEX; SUBSTANCE P; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 63149136975     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0809130106     Document Type: Article

References (30)

1. Jemal A, et al. (2003) Cancer Statistics, 2003. CA Cancer J Clin 53:5-26.
2. Patel HJ, Ramkissoon SH, Patel PS, Rameshwar P (2005) Transformation of breast cells by truncated neurokinin-1 receptor is secondary to activation by preprotachykinin-A peptides. Proc Natl Acad Sci USA 102:17436-17441.
3. Rao G, et al. (2004) Facilitating role of preprotachykinin-I gene in the integration of breastcancer cells within the stromalcompartmentofthe bone marrow: Amodelof early cancer progression. Cancer Res 64:2874-2881.
4. Corcoran KE, et al. (2008) Mesenchymal stem cells in early entry of breast cancer into bone marrow. PLoS ONE 3:e2563.
5. Rameshwar P, Oh HS, Yook C, Gascon P, Chang VT (2003) Substance p-fibronectin- cytokine interactions in myeloproliferative disorders with bone marrow fibrosis. Acta Haematol 109:1-10.
6. PennefatherJN, et al. (2004)Tachykininsand tachykinin receptors: Agrowing family. Life Sci 74:1445-1463.
7. Leeman SE, Aronin N, Ferris C (1982) Substance P and neurotensin. Recent Prog Horm Res 38:93-132.
8. Reddy BY, Trzaska KA, Murthy RG, Navarro P, Rameshwar P (2008) Neurokinin receptors as potential targetsin breast cancer treatment. Curr Drug Discov Technol 5:15-19.
9. Nowicki M, Ostalska-Nowicka D, Miskowiak B (2008) In vitro substance P-dependent induction of bone marrow cells in common (CD10) acute lymphoblastic leukaemia. Leuk Res 32:97-102.
10. Tansky MF, Pothoulakis C, Leeman SE (2007) Functional consequences of alteration of N-linked glycosylation sites on the neurokinin 1 receptor. Proc Natl Acad Sci USA 104:10691-10696.
11. Hennig IM, Laissue JA, Horisberger U, Reubi JC (1995)Substance- Preceptorsin human primaryneoplasms: Tumoral and vascular localization. Int J Cancer 61:786-792.
12. Taborga M,Corcoran KE. FernandesN,Ramkissoon SH, Rameshwar P (2007)G-coupled protein receptorsand breast cancer progression: Potential drug targets. Mini Rev Med Chem 7:245-251.
13. Corcoran KE, Malhotra A, Molina CA, Rameshwar P (2008) Stromal-derived factor- 1{alpha} induces a non-canonical pathway to activate the endocrine-linked Tac1 gene in non-tumorigenic breastcells. J Mol Endocrinol 40:113-123.
14. Oh HS, et al. (2004) Bone marrow stroma influences transforming growth factor-(beta) production in breast cancer cells to regulate c-myc activation of the preprotachykinin-I gene in breastcancer cells. Cancer Res 64:6327-6336.
15. Greco SJ, Smirnov SV, Murthy RG, Rameshwar P (2007) Synergy between the RE-1 silencer of transcription and NF{kappa}B in the repression of the neurotransmitter gene TAC1 in human mesenchymal stem cells. J BiolChem 282:30039-30050.
16. Spencer EM,et al. (2006) Regulation and role of REST and REST4 variants in modulation of gene expression in in vivo and in vitro in epilepsy models. Neurobiol Dis 24:41-52.
17. Lunyak VV,Rosenfeld MG (2005) No rest for REST: REST/NRSF regulation ofneurogenesis. Cell 121:499.
18. Ballas N, Grunseich C, Lu DD, Speh JC, Mandel G (2005) REST and its corepressors mediate plasticity of neuronal gene chromatin throughout neurogenesis. Cell 121:645-657.
19. Majumder S (2006) REST in good times and bad: Roles in tumor suppressor and oncogenic activities. Cell Cycle 5:1929-1935.
20. Weissman AM (2008) How much REST is enough? Cancer Cell 13:381-383.
21. Su X, et al. (2006) Abnormal expression of REST/NRSF and Myc in neural stem / progenitor cells causes cerebellar tumors by blocking neuronal differentiation. Mol Cell Biol 26:1666-1678.
22. Zhao JJ, et al. (2003) Human mammary epithelial cell transformation through the activation of phosphatidylinositol 3-kinase. Cancer Cell 3:483-495.
23. Westbrook TF, et al (2005) A genetic screen for candidate tumor suppressors identifies REST. Cell 121:837-848.
24. Coulson JM, Fiskerstrand CE, Woll PJ, Quinn JP (1999) Arginine vasopressin promoter regulation is mediated by a neuron-restrictive silencer element in small cell lung cancer. Cancer Res 59:5123-5127.
25. Qian J, et al. (2001) Cloning of human preprotachykinin-I promoter and the role of cyclic adenosine 5'-monophosphate response elements in its expression by IL-1 and stem cell factor. J Immunol 166:2553-2561.
26. Coulson JM (2005)Transcriptional regulation: Cancer, neurons and the REST. Curr Biol 15:R665-R668.
27. Downward J (2005) RNA interference libraries prove their worth in hunt for tumor suppressor genes. Cell 121:813-815.
28. Coulson JM, Edgson JL, Woll PJ, Quinn JP (2000) A splice variant of the neuron- restrictive silencer factor repressor is expressed in small cell lung cancer: A potential role in derepression of neuroendocrine genes and useful clinical marker. Cancer Res 60:1840-1844.
29. Greco SJ, Rameshwar P (2007) Enhancing effect of IL-1(alpha) on neurogenesis from adult human mesenchymal stem cells: Implication for inflammatory mediators in regenerative medicine. J Immunol179:3342-3350.
30. Singletary SE, et al. (2002)Revision of the American Joint Committee on Cancerstaging system for breastcancer. J Clin Oncol 20:3628-3636.